Watson David O.

General Counsel

1 company

Strong

Trades Analyzed

12M Win Rate

75.0%

Avg 3M Return

+9.4%

Avg 12M Return

+18.6%

Watson David O. is a General Counsel at Apellis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 11 sells.

Estimated insider holdings value: $5.9M based on current market prices.

Holdings by Company

APLSJan 28, 2026

Current Shares144.5K

Value$5.93M

Net Activity-158,163

Bought: 0Sold: 158.2K

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 29, 2025	APLS Apellis Pharmaceuticals, Inc.	General Counsel	Sell	695	$29.52	$20,518.90	-0.5%	-38.2%	-21.8%
Jan 22, 2025	APLS Apellis Pharmaceuticals, Inc.	General Counsel	Sell	3,323	$30.43	$101,103.94	-2.2%	-42.8%	-27.6%
Jan 17, 2025	APLS Apellis Pharmaceuticals, Inc.	General Counsel	Sell	2,201	$29.96	$65,938.00	-2.0%	-39.2%	-33.4%
Jan 13, 2025	APLS Apellis Pharmaceuticals, Inc.	General Counsel	Sell	4,965	$28.70	$142,505.93	-4.4%	-32.4%	-25.4%
Dec 11, 2024	APLS Apellis Pharmaceuticals, Inc.	General Counsel	Sell	5,000	$34.24	$171,175.00	-4.2%	-24.9%	-26.6%
Feb 12, 2024	APLS Apellis Pharmaceuticals, Inc.	General Counsel	Sell	781	$67.77	$52,925.95	-0.7%	-36.5%	-57.9%
Jan 29, 2024	APLS Apellis Pharmaceuticals, Inc.	General Counsel	Sell	906	$64.14	$58,109.21	-0.9%	-26.8%	-55.2%
Jan 22, 2024	APLS Apellis Pharmaceuticals, Inc.	General Counsel	Sell	4,184	$65.00	$271,943.26	-3.8%	-27.2%	-54.0%
Jan 16, 2024	APLS Apellis Pharmaceuticals, Inc.	General Counsel	Sell	4,240	$66.81	$283,268.46	-3.7%	-22.3%	-56.2%
Dec 19, 2023	APLS Apellis Pharmaceuticals, Inc.	General Counsel	Sale+OE	3,905	$57.23	$223,471.79	-2.1%	-3.0%	-41.3%